Compare Enveric Biosciences Inc (ENVB) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Vanguard Total International Stock Index Fund ETF — how do they compare? Enveric Biosciences Inc trades at $1.32 (market cap $5.32M), while Vanguard Total International Stock Index Fund ETF trades at $84.16. The key difference: Vanguard Total International Stock Index Fund ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | VXUS | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.40 | $87.06 |
52-Week Low | $1.28 | $68.24 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VXUS trades at $83.96, down 0.83% on the day, with a bullish technical signal driven by moving averages. The ETF provides broad international stock exposure across developed and emerging markets, with over 8,700 holdings. Recent news highlights its role in diversification and cost efficiency compared to peers.
The outlook for VXUS hinges on global equity performance relative to the US, with potential upside from valuation discounts. Risks include persistent inflation and growth concerns outside the US. Analyst sentiment is mixed, with some caution due to macroeconomic headwinds affecting international markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
